Davis Gregory D (CIK 0002041855)

Latest company ownership

SGMO - SANGAMO THERAPEUTICS, INC

Role: Head of Research & Technology

Shares held

193,791

Last filed at

Nov 26, 2025

Confidence Score

50.4

2025Q4

Confidence Score History

2024Q4 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 24, 2025	Nov 26, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	52.5	-723	-0.37%	✗	$301.2
Oct 22, 2025	Oct 24, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	47.5	-6,708	-3.33%	✗	$4.4K
Aug 24, 2025	Aug 26, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	52.5	-723	-0.36%	✗	$423.9
Jul 22, 2025	Jul 24, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	47.5	-6,708	-3.21%	✗	$3.2K
May 24, 2025	May 28, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	52.5	-723	-0.35%	✗	$342.2
Apr 22, 2025	Apr 24, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	47.5	-6,708	-3.10%	✗	$5.2K
Feb 24, 2025	Feb 26, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	90.0	+48,514	28.95%	✗	$1.2K
Jan 22, 2025	Jan 24, 2025	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	46.3	-30,456	-15.38%	✗	$35K
Nov 24, 2024	Nov 26, 2024	SANGAMO THERAPEUTICS, INC	Head of Research & Technology	Sell	50.0	-1,226	-0.60%	✗	$2.3K